ClinicalTrials.gg
CompletedNCT06854718PWDUpdated Nov 18, 2026

Pain With Dementia

An interventional study of Caregiver-Assisted Pain Coping Skills Training (CG-PCST) in Pain, Dementia, Mild and Dementia, Moderate, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Duke University · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 18, 2026Now CompletedStudy documents posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Not applicable
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Pain by Duke University — 8 open to participants now, 8 under way, none of them phase 3. Pain · Duke University.

Enrollment
22nd of 46
65 · median 64
Started
2025
with 3 others
No phase
29 of 51
6 open now
Registered
49th of 51
by date

Among the 51 studies in Pain by Duke University, this one is the 22nd largest by enrollment of the 46 interventional ones that give a count, is one of 4 that started in 2025, is one of 29 with no phase, and was the 49th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

8 of the 51 studies in Pain by Duke University are open now, in 2 countries. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 50 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Pain by Duke University, or all of them as a file.
02

Study summary

The purpose of the study is to develop a caregiver-assisted pain coping skills training program for older adults who have pain and mild to moderate dementia and are living at home with a family caregiver. The investigators are planning to recruit 30 patient-caregiver dyads (60 individuals).

Read the detailed description

Involving caregivers in a pain coping skills protocol is likely to optimize treatment outcomes in several ways.

First, people with dementia (PWD) are likely to have difficulty learning and remembering pain coping skills; training the caregiver to coach the patient in the use of the skills is likely to improve the patients' acquisition and ongoing use of learned skills.

Second, caregiver involvement in pain coping skills training may increase their understanding of how to gauge how much pain the PWD is experiencing and the impact of pain management strategies. This understanding is increasingly important as the patient's disease progresses, and s/he is less able to report pain verbally.

Third, caregiver-assisted pain management training may enhance caregivers' self-confidence for managing the patient's pain.

Finally, by participating in the pain coping skills training protocol, caregivers may learn coping skills (such as relaxation) that can help them manage the stress associated with caring for a PWD and pain which can be significant.

03

Conditions studied

  • Pain
  • Dementia, Mild
  • Dementia, Moderate
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients:

  • Mild or moderate dementia
  • Pain on most days for at least 3 months that interferes with function
  • Living at home (non-institutional)
  • Age ≥ 50
  • English Speaking

Caregivers:

  • Provides on average at least 4 hours/day of care/assistance to the patient
  • Age ≥ 18
  • English Speaking

Exclusion criteria

Exclusion Criteria:

Patient and caregivers

  • Lacking capacity for interview or unable to provide /assent.
  • Visual or hearing impairments or severe behavioral problems that preclude participation.
  • Too sick to participate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
65 participants (actual)

Study arms

  • Other
    Patient-Caregiver Dyads

    Patient and caregiver dyads will receive five 45-60 minute sessions over 6-8 week period. This will be over videoconference with a masters-level therapist. All sessions will be audio recorded.

    Behavioral: Caregiver-Assisted Pain Coping Skills Training (CG-PCST)

Interventions

  • BehavioralCaregiver-Assisted Pain Coping Skills Training (CG-PCST)

    Patient-caregiver dyads will receive five, forty-to-sixty-minute sessions over a six-to-eight-week period with a therapist to learn pain coping skills. These include training caregivers in strategies for assessing patient pain, including nonverbal pain behaviors (e.g., grimacing, bodily tension, labored breathing), which will become increasingly important as the patient's ability to express pain verbally decreases. The therapist will also train the caregiver to coach the patient in the use of the skills during activities that are challenging because of pain. We will focus on increasing positive patient-caregiver interactions and patient engagement in valued activities. Throughout the training, the therapist will help the patient and caregiver learn strategies for fostering regular home practice and application of the skills, identify challenges in using the skills, and find strategies for coping with challenges.

06

What researchers measure

Primary outcomes

  1. Client Satisfaction Questionnaire

    Caregiver completes. Score range: 1-4; higher score indicates better outcome

    Time frame: Post-intervention (approximately 8 weeks)

Secondary outcomes

  1. Quality of life in Alzheimer's Disease Caregiver version and Patient version

    Patient and Caregiver will complete Patient QOL. Score range: 13-52; higher score indicates better outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  2. Brief Pain Inventory-Interference Items

    Patient and Caregiver will complete Patient pain interference. Score range: 0-10; higher score indicates worse outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  3. Caregiver Self-Efficacy in Pain Management

    Caregiver will complete caregiver self-efficacy. Score range: 0-10; higher score indicates better outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  4. Numeric pain scale & verbal descriptor

    Patient will complete patient pain intensity. Score range: 0-19; higher score indicates worse outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  5. Checklist of nonverbal pain indicators

    Caregiver will complete patient pain intensity. Score range: 0-10; higher score indicates worse outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  6. Zarit burden interview

    Caregivers will complete caregiver burden. Score range: 0-88; higher score indicates worse outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  7. Caregiver appraisal-satisfaction scale

    Caregiver will complete caregiver satisfaction. Score range: 0-10; higher score indicates worse outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

  8. Neuropsychiatric inventory

    Caregiver will complete patient neuropsychiatry behaviors. Score range: 0-144; higher score indicates worse outcome

    Time frame: Baseline and post-intervention (approximately 8 weeks)

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Sep 2026, 13 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 13 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Dec 2026 → Sep 2026 and completion Dec 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2025
First posted
Mar 3, 2025
StartActual
Aug 13, 2025
Primary completionActual
Sep 20, 2026was Dec 2026
CompletionActual
Sep 20, 2026was Dec 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 18, 2026
Primary completion
Dec 1, 2026→Sep 20, 2026 (actual)
Nov 18, 2026
Study completion
Dec 1, 2026→Sep 20, 2026 (actual)
Nov 18, 2026
Enrollment
60 (estimated)→65 (actual)
Nov 18, 2026
Documents
Show all 1 update
  1. Nov 18, 2026
    Recruiting→Completed
    Primary completion Dec 1, 2026→Sep 20, 2026 (now actual)
    Study completion Dec 1, 2026→Sep 20, 2026 (now actual)
    Enrollment 60 (estimated)→65 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06854718
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Mar 3, 2025
Start date
Aug 13, 2025
Primary completion
Sep 20, 2026
Completion
Sep 20, 2026
Last update
Nov 18, 2026

Study contacts

Laura Porter, Ph.D
principal investigator · Duke University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion